<DOC>
	<DOCNO>NCT00658268</DOCNO>
	<brief_summary>The primary focus study investigate whether increase bone density graft revision arthroplasty hip cause decrease micromotion implant relative femur .</brief_summary>
	<brief_title>Bisphosphonates Impaction Grafting Hip Revision</brief_title>
	<detailed_description>Morsellized compact bone allograft use revision arthroplasty hip . Treating graft locally antiresorptive substance bisphosphonate decrease graft resorption animal study lead remain bone density human series 16 patient . In present study investigate increase bone density graft also cause decreased micromotion implant relative femur . 36 patient plan participate 1:1 randomize prospective study compare bisphosphonate Clodronate saline . Primary outcome micromotion first year also secondary parameter late micromotion ( 12 24 month ) , re-loosening subjective outcome safety . We hypothesize rinse graft bisphosphonate solution prevents resorption therefore may reduce risk mechanical failure . Patients follow radiogram , RSA ( radiostereography ) preop , postop , 6 week , 12 24 month subjective month subjective parameter include Womac SF 12 . The treatment simple , cheap appear virtually risk-free .</detailed_description>
	<mesh_term>Clodronic Acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Patients aseptic loosening osteolysis schedule hip revision use allograft impaction technique Obtained informed consent Pregnancy exclude woman childbearing age Patients know renal disease Screatinine &gt; 175 mcmol/L Patients Scalcium 2.75 mmol/L Patients diagnose Rheumatoid arthritis Patients active primary hyperparathyroidism</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Surgical procedure operative</keyword>
	<keyword>Prosthesis implantation</keyword>
	<keyword>Arthroplasty replacement</keyword>
</DOC>